ADVIL ALLERGY AND CONGESTION RELIEF
Peakchlorpheniramine maleate, ibuprofen, and phenylephrine hydrochloride
NDAORALTABLET
Approved
Dec 2011
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
3/8 — Basic
ADVIL ALLERGY AND CONGESTION RELIEF (chlorpheniramine maleate, ibuprofen, and phenylephrine hydrochloride) by GSK is cyclooxygenase inhibitors [moa]. First approved in 2011.
Drug data last refreshed 37m ago · AI intelligence enriched 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Advil Allergy and Congestion Relief is an oral tablet combining ibuprofen (NSAID), chlorpheniramine maleate (antihistamine), and phenylephrine HCl (decongestant) to address allergy and cold symptoms simultaneously. It works via cyclooxygenase inhibition to reduce inflammation and pain while providing symptomatic relief of congestion and allergic reactions. The triple-action formulation targets patients seeking convenience through a single-dose solution.
Peak
Product is at peak commercial maturity in the OTC allergy/cold category with moderate competitive pressure (30/100), suggesting stable but not growth-oriented team expansion.
Mechanism of Action
Cyclooxygenase Inhibitors
Pharmacologic Class:
Nonsteroidal Anti-inflammatory Drug
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Roles on this product are concentrated in OTC commercial, marketing, and retail execution rather than clinical, regulatory, or scientific functions. Career growth potential is limited by the mature stage and lack of novel indication development, making this best suited for professionals seeking hands-on field sales, brand building, or consumer marketing experience rather than clinical advancement.
Brand Manager
Worked on ADVIL ALLERGY AND CONGESTION RELIEF at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.